Put simply, semaglutide works by stimulating GLP-1 (glucagon-like peptide-1) receptors, which are responsible for appetite and food intake regulation
Although neither medication is officially approved as a primary treatment for weight loss, both have demonstrated significant potential for weight loss among individuals with type 2 diabetes
Obesity Obesity, reflected by a high body mass index (BMI), is associated with an increased risk of breast cancer in postmenopausal women, whereas this association is not observed in premenopausal women (19)
For more detail on tolerability questions, see Retatrutide Side Effects
When people on TikTok say they're "microdosing" semaglutide at 0.25 mg per week, they are, in many cases, simply taking the FDA-approved starting dose of Ozempic